1999年11月
Impact at cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction
AMERICAN JOURNAL OF CARDIOLOGY
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 84
- 号
- 9
- 開始ページ
- 1074
- 終了ページ
- +
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1016/S0002-9149(99)00501-9
- 出版者・発行元
- EXCERPTA MEDICA INC
Cilostazol, an antiplatelet drug that also may inhibit smooth muscle proliferation, was given together with aspirin after primary stenting to treat patients with acute myocardial infarction. In a randomized controlled trials of 50 patients, clinical and angiographic outcome at 6 months was significantly improved with cilostazol, depicting a significantly smaller late loss and/or loss index.
- リンク情報
- ID情報
-
- DOI : 10.1016/S0002-9149(99)00501-9
- ISSN : 0002-9149
- Web of Science ID : WOS:000083479900021